Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
about
Total Synthesis of Bryostatin 8 Using an Organosilane-Based Strategy.REDOR NMR Reveals Multiple Conformers for a Protein Kinase C Ligand in a Membrane Environment.Addressing supply issues for natural products in the clinic.The Who, Why, and How of Small-Molecule Production in Invertebrate Microbiomes: Basic Insights Fueling Drug Discovery.Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1
P2860
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@en
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@nl
type
label
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@en
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@nl
prefLabel
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@en
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@nl
P2093
P2860
P50
P356
P1433
P1476
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
@en
P2093
Akira J Shimizu
Clayton T Hardman
Jack L Sloane
Jana K Maclaren
Matthew C Stevens
Matthew S Jeffreys
Paul A Wender
Ryan V Quiroz
Stephen Ho
Steven M Ryckbosch
P2860
P304
P356
10.1126/SCIENCE.AAN7969
P407
P50
P577
2017-10-01T00:00:00Z